SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on new 24-month HOPE-3 open-label extension data for deramiocel, which traders view as supportive of sustained slowing in upper-limb decline and relevant to the FDAs review. Many are bullish on approval prospects, while skeptics question how persuasive the open-label results are and whether disputes over the trials statistical analysis plan will affect the decision.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods product-expansion announcementsincluding planned 24/7 stock trading, perpetual futures and new social featuresare fueling discussion, with some traders welcoming broader access while others criticize the presentation and worry about round-the-clock, leveraged trading. Complaints about a separate app outage and frustration with the stocks price action add to the mixed reaction.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal fourth-quarter earnings and guidance are the main focus, with traders looking for confirmation that AI-driven memory demand, tight DRAM and NAND supply, and pricing strength can persist. Bullish expectations for strong results compete with concerns that optimism is already priced in and the stock could sell off on the news, especially if managements outlook raises doubts about the memory cycles duration.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are under pressure amid concerns about slowing growth, weaker advertising demand and competition from Amazon and automated ad platforms. Traders are split between seeing the companys cash generation and low valuation as support and expecting further declines, with many criticizing management and a smaller group anticipating a rebound.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A pause in the federal marijuana-rescheduling hearing tied to a GAO report on gaps in drug-scheduling procedures has renewed concerns about delays to the potential move to Schedule III. Traders are split between fearing the delay removes a near-term catalyst and calling the selloff an overreaction because the rescheduling process remains underway.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised FY2026 revenue outlook, driven by stronger demand for Amtagvi and Proleukin, sparked a sharp rally and renewed confidence in its commercial growth. Traders are broadly bullish and speculate that heavy short interest could amplify the move, while others warn about overvaluation, profit-taking, and possible dilution; upcoming lung-cancer data is also a focus.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

A 737 MAX flight-guidance software glitch and the FAAs review have put Boeings MAX 10 certification and delivery outlook under scrutiny. Traders are split between viewing the issue as a manageable, fixable problem and seeing another setback to Boeings safety and execution recovery.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Rising Treasury yields and expectations for further Fed rate hikes, alongside oil-price and geopolitical inflation concerns, are weighing on the Dow and broader equities. Traders are split between warning of a deeper pullback and viewing the weakness as a buying opportunity, with some pointing to market resilience.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas reported positive Phase 3 results for HETLIOZ in delayed sleep-wake phase disorder are driving attention, with traders welcoming the trial outcome while some question the commercial prospects given generic competition. The broader discussion also reflects skepticism about the companys execution and the stocks ability to sustain gains.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO shares plunged after FHFA changes put VantageScore alongside FICO on a single mortgage-pricing grid, while Rocket Mortgages planned preference for VantageScore and its lower pricing sharpened concerns about competition, mortgage-score revenue, and FICOs pricing power. Traders are split between viewing the move as a lasting erosion of FICOs market moat and calling the selloff an overreaction, with some looking for a rebound and others expecting further declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evernorths SPAC merger and Nasdaq transition are the main focus, alongside its planned XRP treasury of roughly 473 million tokens. Traders are treating XRPN as an equity proxy for XRP and debating the mergers timing, potential share backing and warrant leverage, while noting sharp moves and trading halts; views on the risk and valuation differ.

Armada Acquisition Corp. II (NASDAQ:AACI) Stock Price Up 0.1% - What's Next?

Armada Acquisition Corp. II (NASDAQ:AACI) Stock Price Up 0.1% - Here's Why...

Evernorth Announces Appointment of New Board Members and Senior Executives Ahead of Anticipated Public Listing

Evernorth Announces Appointment of New Board Members and Senior Executives Ahead of Anticipated Public Listing Evernorth Announces Appointment of New Board Members and Senior Executives Ahead of...

Armada Acquisition Corp. II (NASDAQ:AACI) Shares Up 0.1%  - What's Next?

Armada Acquisition Corp. II (NASDAQ:AACI) Trading 0.1% Higher - Time to Buy...

Evernorth Advances Business Combination with Public S-4 Filing

Evernorth Advances Business Combination with Public S-4 Filing Evernorth Advances Business Combination with Public S-4 Filing PR Newswire SAN FRANCISCO, March 18, 2026 SAN FRANCISCO, March 18, 2026...

Armada Acquisition Corp. II (NASDAQ:XRPN) Trading Up 0.1% - Still a Buy?

Armada Acquisition Corp. II (NASDAQ:XRPN) Trading Up 0.1% - Here's What Happened...

Evernorth Announces Confidential Submission of a Draft Registration Statement on Form S-4 to the SEC

Evernorth Announces Confidential Submission of a Draft Registration Statement on Form S-4 to the SEC Evernorth Announces Confidential Submission of a Draft Registration Statement on Form S-4 to the...

Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025

Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025 Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025 PR Newswire MIAMI, Oct. 29...

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Extremely Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

Evernorth Holdings Inc.

Traders are closely monitoring the upcoming Armada merger vote on September 30, which could finalize the Nasdaq listing for Evernorth with over 473 million XRP on its balance sheet.

Investors are shifting focus to high-leverage warrant opportunities, citing potential arbitrage gaps and historical upside performance seen in similar SPAC structures.

Frequent volatility-induced T12 trading halts are causing significant friction and debate among day traders trying to capture quick gains during the run-up.

Current Price	$12.90
Prev Close	$10.58
Open	$12.10
Dividend Yield	0.00%
50-Day Moving Average	$10.51
Beta	0.54
Avg. Volume	42,962.31
PE Ratio	108.35

52-Week High	$13.67
52-Week Low	$10.10
Market Capitalization	$334.06M
EPS (Annual)	$0.0561
Price to Book	1.47
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

XRPN Fundamentals